Patent Assignment Agreement (English Translation)Patent Assignment Agreement • July 14th, 2011 • Tongli Pharmaceuticals (USA), Inc. • Pharmaceutical preparations
Contract Type FiledJuly 14th, 2011 Company Industry
LOAN AGREEMENTLoan Agreement • July 14th, 2011 • Tongli Pharmaceuticals (USA), Inc. • Pharmaceutical preparations
Contract Type FiledJuly 14th, 2011 Company IndustryTHIS LOAN AGREEMENT, is made this Seventeenth day of February ,2011, by and among Tongli Pharmaceuticals(USA), Inc., a Delaware corporation (hereinafter knows as “BORROWER”) and Hua Sky Investment Ltd, organized under the Business Companies Act of the British Virgin Islands (hereinafter knows as “LENDER”). BORROWER and LENDER shall collectively be known herein as “the Parties”. In determining the rights and duties of the Parties under this Loan Agreement, the entire document must be read as a whole.
LOAN AGREEMENT (English Translation)Loan Agreement • July 14th, 2011 • Tongli Pharmaceuticals (USA), Inc. • Pharmaceutical preparations
Contract Type FiledJuly 14th, 2011 Company IndustryTHIS LOAN AGREEMENT, is made this tenth day of January, 2009, by and among Harbin Tianmu Pharmaceuticals Co., Ltd., a Chinese corporation (hereinafter knows as “BORROWER”) and Mr. Mingli Yao (hereinafter knows as “LENDER”). BORROWER and LENDER shall collectively be known herein as “the Parties”. In determining the rights and duties of the Parties under this Loan Agreement, the entire document must be read as a whole.
Land Use Right Transfer AgreementLand Use Right Transfer Agreement • July 14th, 2011 • Tongli Pharmaceuticals (USA), Inc. • Pharmaceutical preparations
Contract Type FiledJuly 14th, 2011 Company IndustryBased on the Law of the Peoples Republic of China on Land Contract in Rural Areas, Party B will receive planting rights and operation rights for the land after paid in cash. Both parties agree the following terms:
Patent Assignment Termination AgreementPatent Assignment Termination Agreement • July 14th, 2011 • Tongli Pharmaceuticals (USA), Inc. • Pharmaceutical preparations
Contract Type FiledJuly 14th, 2011 Company Industry
LOAN AGREEMENT (English Translation)Loan Agreement • July 14th, 2011 • Tongli Pharmaceuticals (USA), Inc. • Pharmaceutical preparations
Contract Type FiledJuly 14th, 2011 Company IndustryTHIS LOAN AGREEMENT, is made this thirty-first day of December, 2009, by and among Harbin Tianmu Pharmaceuticals Co., Ltd., a Chinese corporation (hereinafter knows as “BORROWER”) and Harbin Tianmu Real Estate Development Co., Ltd. a Chinese corporation (hereinafter knows as “LENDER”). BORROWER and LENDER shall collectively be known herein as “the Parties”. In determining the rights and duties of the Parties under this Loan Agreement, the entire document must be read as a whole.
LOAN AGREEMENTLoan Agreement • July 14th, 2011 • Tongli Pharmaceuticals (USA), Inc. • Pharmaceutical preparations
Contract Type FiledJuly 14th, 2011 Company IndustryTHIS LOAN AGREEMENT, is made this tenth day of January, 2011, by and among American Tony Pharmaceutical Inc (hereinafter knows as “BORROWER”) and Mr. Mingli Yao(hereinafter knows as “LENDER”). BORROWER and LENDER shall collectively be known herein as “the Parties”. In determining the rights and duties of the Parties under this Loan Agreement, the entire document must be read as a whole.
Supplementary AgreementSupplementary Agreement • July 14th, 2011 • Tongli Pharmaceuticals (USA), Inc. • Pharmaceutical preparations
Contract Type FiledJuly 14th, 2011 Company Industry
Class II New Drug Approval Assignment AgreementClass Ii New Drug Approval Assignment Agreement • July 14th, 2011 • Tongli Pharmaceuticals (USA), Inc. • Pharmaceutical preparations
Contract Type FiledJuly 14th, 2011 Company Industry
Tongli Pharmaceutical (USA), Inc Independent Director’s Complementary AgreementIndependent Director’s Complementary Agreement • July 14th, 2011 • Tongli Pharmaceuticals (USA), Inc. • Pharmaceutical preparations
Contract Type FiledJuly 14th, 2011 Company IndustryThis Complementary agreement is made as of the 1st day of April, 2009 and is by and Tongli Pharmaceutical (USA), Inc., a Delaware corporation (hereinafter referred to as the “Company”) and Hui Shao.